/주식/TSHA
TSHA

TSHA

USD

Taysha Gene Therapies Inc. Common Stock

$4.270-0.020 (-0.466%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$4.290

고가

$4.540

저가

$4.000

거래량

5.02M

기업 기본 정보

시가총액

1.2B

산업

생명공학

국가

United States

거래 통계

평균 거래량

6.14M

거래소

NMS

통화

USD

52주 범위

저가 $1.05현재가 $4.270고가 $5.508

관련 뉴스

Analyst Upgrades

Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13

Raymond James analyst Christopher Raymond initiates coverage on Taysha Gene Therapies with a Strong Buy rating and announces Price Target of $13.

더 보기
Raymond James Initiates Coverage On Taysha Gene Therapies with Strong Buy Rating, Announces Price Target of $13
GlobeNewswire

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (NASDAQ:TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies

더 보기
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)